Published 2021 Archives - healthdatainsight.org.uk

Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting

Sep 1, 2021

Home » NDRS » Page 6 Knott CS, Heffernan K, Nikitas FS, Shukla U, Starkie-Camejo H. 812P Demographics and survival outcomes in patients with advanced or recurrent endometrial cancer (EC) following platinum-based doublet (PBD) in the English real-world (RW) setting....

A registry study of relapsed or refractory multiple myeloma pre-exposed to 3 or more therapies including a proteasome inhibitor, an immunomodulatory agent and cd38-targeted monoclonal antibody therapy in England

Jun 10, 2021

Home » NDRS » Page 6 Elsada A, Zalin-Miller A, Knott CS, Caravotas L. A registry study of relapsed or refractory multiple myeloma pre-exposed to 3 or more therapies including a proteasome inhibitor, an immunomodulatory agent and cd38-targeted monoclonal antibody...

Surgical decisions in older women with early breast cancer: patient and disease factors

Mar 11, 2021

Home » Publications » Published 2021 Jauhari Y, Gannon MR, Dodwell D, Horgan K, Clements K, Medina J, et al.British Journal of Surgery, Volume 108, Issue 2, February 2021, Pages 160–167. https://doi.org/10.1093/bjs/znaa042 Abstract: Background Studies reporting...

Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane project.

Nov 17, 2020

Home » Publications » Published 2021 Shaaban AM, Hilton B, Clements K, Provenzano E, Cheung S, Wallis MG, et al.Br J Cancer 2021; 124:1009–17; https://doi.org/10.1038/s41416-020-01152-5 Abstract: Background The Sloane audit compares screen-detected ductal carcinoma in...